Clinical Trial Update: Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Florbetapir F-18 PET imaging of beta-amyloid in Parkinson's disease patients has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Florbetapir F-18 (florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-03-11